Nouveau système de score pour le diagnostic des pré dispositions aux cancers du sein et de l'ovaire associées à BRCA1/2

Translated title of the contribution: A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition

Bernard Bonaïti*, Flora Alarcon, Valérie Bonadona, Sophie Pennec, Nadine Andrieu, Dominique Stoppa-Lyonnet, Hervé Perdry, Catherine Bonaïti-Pellié, Emmanuelle Barouk, Odile Béra, Yves Jean Bignon, Bruno Buecher, Olivier Caron, François Cornélis, Hélène Dreyfus, Catherine Dugast, François Eisinger, Viviane Feillel, Anne Floquet, Jean Pierre FrickerBrigitte Gilbert-Dussardier, Laurence Gladieff, Agnès Hardouin, Laetitia Huiart, Christine Lasset, Valérie Layet, Alain Lortholary, Sylvie Manouvrier, Christine Maugard, Tan Dat Nguyen, Catherine Noguès, Laurence Olivier-Faivre, Julie Tinat, Laurence Vénat-Bouvet, Philippe Vennin, Hélène Zattara-Cannoni

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


Criteria have been proposed for genetic testing of breast and ovarian cancer susceptibility genes BRCA1 and BRCA2. Using simulations, this study evaluates the efficiency (sensitivity, positive predictive value [PPV] and specificity) of the various criteria used in France. The efficiency of the criteria published in 1998, which are largely used, is not optimal. We show that some extensions of these criteria provide an increase in sensitivity with a low decrease in specificity and PPV. The study shows that scoring systems (Manchester, Eisinger) have similar efficiency that may be improved. In this aim, we propose a new scoring system that takes into account unaffected individuals and kinship coefficients between family members. This system increases sensitivity without affecting PPV and specificity. Finally, we propose a two-step procedure with a large screening by the physician for recommending genetic counselling, followed by a more stringent selection by the geneticist for prescribing genetic testing. This procedure would result in an increase of genetic counselling activity but would allow the identification of almost 80% of mutation carriers among affected individuals, with a mutation detection rate of 15% and a specificity of 88%.

Translated title of the contributionA new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition
Original languageFrench
Pages (from-to)779-795
Number of pages17
JournalBulletin du Cancer
Issue number7
Publication statusPublished - Jul 2011


  • BRCA1 and BRCA2 genes
  • Breast cancer
  • Efficiency
  • Genetic testing
  • Hereditary predisposition
  • Ovarian cancer


Dive into the research topics of 'A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition'. Together they form a unique fingerprint.

Cite this